X-linked lymphoproliferative syndrome 2 is a recessive disorder caused by mutations of the XIAP gene. It is characterized by immunodeficiency in particular against EBV infections.
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|||
|
|
|
|
||
| 1. |
Rigaud S et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
|
| 2. |
Worthey EA et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease.
|
| 3. |
Yang X et al. (2012) Clinical and genetic characteristics of XIAP deficiency in Japan.
|
| 4. |
Latour S et al. (2015) XIAP deficiency syndrome in humans.
|
| 5. |
Dziadzio M et al. (2015) Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency.
|
| 6. |
Nishida N et al. (2015) Dysgammaglobulinemia Associated With Glu349del, a Hypomorphic XIAP Mutation.
|
| 7. |
Zhao M et al. (2010) A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly.
|
| 8. |
Pachlopnik Schmid J et al. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
|
| 10. |
Wikipedia article Wikipedia EN (X-linked_lymphoproliferative_disease)
|